Document reference

2024/2606(DEA)  
Inclusion of the drug precursor Isopropylidene (2-(3,4-methylenedioxyphenyl)acetyl)malonate (IMDPAM) and other substances in the list of scheduled substances  
Basic information  

2024/2606(DEA)

DEA - Delegated acts procedure


Subject
7.30.30.04 Action to combat drugs and drug-trafficking

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
28/02/2024
Non-legislative basic document published
C(2024)01219
28/02/2024
Initial period for examining delegated act 2 month(s)
13/03/2024
Committee referral announced in Parliament
12/04/2024
Delegated act not objected by Council
23/04/2024
Decision by Parliament
T9-0314/2024
Technical information  
Procedure reference
2024/2606(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Legal basis
Rules of Procedure EP 0111-p6
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
LIBE/9/14299
Documentation gateway  
  • European Parliament 
    Recommendation for early non-objection of delegated act
       
    B9-0213/2024  
    10/04/2024
    EP
     
    Text adopted by Parliament, single reading
       
    T9-0314/2024  
    23/04/2024
    EP
     
  • European Commission 
    Non-legislative basic document
     
    C(2024)01219  
    28/02/2024
    EC
     
  • All 
    Non-legislative basic document
       
    C(2024)01219  
    28/02/2024
    EC
     
    Recommendation for early non-objection of delegated act
       
    B9-0213/2024  
    10/04/2024
    EP
     
    Text adopted by Parliament, single reading
       
    T9-0314/2024  
    23/04/2024
    EP